Le Lézard
Classified in: Health, Business
Subjects: OTC, CXP

ForeverGreen Completes Restructuring and Focuses on Growth


LINDON, Utah, December 28, 2017 /PRNewswire/ --

ForeverGreentm Worldwide Corporation (OTCBB: FVRG), a global direct marketing company and provider of health and wellness products has completed its planned consolidation and restructuring of the company, including reducing overhead costs, streamlining the company's product offerings, reducing shipping costs, reduction of personnel and consolidating domestic and foreign warehouse and office spaces. These strategies were directed to reduce overhead and debt, streamline domestic and international operations, improve distribution channels and consolidate the company's product offerings. All of these steps have taken the last year to accomplish, and the company is now seeing the positive impact on the company's model and its profitability.

"This has been a difficult year of transition for ForeverGreen. It was my main objective in 2017, as the company's new CEO, to complete the restructuring of the company, both domestically and internationally and it has taken even longer than I originally thought it would. I believe that while we have reduced in many areas, we can keep and refocus on the key products, marketing messages, technologies and foundational values and heritage that have made ForeverGreen successful. The company's proprietary envelope model has been, and continues to be a unique and successful business model for ForeverGreen. Now, in 2018, the management team will be focusing on sales growth, higher profitability, and net margins to increase our shareholder's value," said ForeverGreen CEO, Rick Redford.

About ForeverGreentm Worldwide Corporation

ForeverGreen Worldwide Corporation was founded in 2004, and develops, manufactures and distributes an expansive line of all-natural products to North America, Europe and Asia, including its global Xpress offering Prodigy-5tm, featuring TransArmortm Nutrient Technology, as well as Pulse-8tm powered L-arginine formula for cardiovascular health. Additional products include PowerStripstm, SolarStripstm, with industry exclusive marine phytoplankton.

Forward-Looking Statement

This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The company's actual results could differ materially from expected results.

For more information: 

Brokers and Analysts:
Chesapeake Group
+1-410-825-3930
[email protected]

SOURCE ForeverGreentm Worldwide Corporation


These press releases may also interest you

at 07:35
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced...

at 07:35
Accuray Incorporated announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife® and Radixact® platforms provide medical care...

at 07:30
Jushi Holdings Inc. ("Jushi" or the "Company") , a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first quarter ended March 31, 2024, after the market closes on Thursday, May...

at 07:30
Ziosoft, a pioneer in 3D/4D AI medical visualization, will feature its unique REVORAS-enabled thoracic surgical planning capabilities at the annual American Association of Thoracic Surgeons (AATS) conference being held April 27 - 29, 2024 in Toronto,...

at 07:30
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received notice of intent...

at 07:25
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation ("the Gates Foundation" or "the...



News published on and distributed by: